A detailed history of Unionview, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Unionview, LLC holds 2,085 shares of LLY stock, worth $1.85 Million. This represents 1.54% of its overall portfolio holdings.

Number of Shares
2,085
Previous 2,085 -0.0%
Holding current value
$1.85 Million
Previous $1.62 Million 16.34%
% of portfolio
1.54%
Previous 1.35%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 29, 2024

BUY
$592.2 - $792.28 $3,553 - $4,753
6 Added 0.29%
2,085 $1.62 Million
Q3 2023

Oct 30, 2023

SELL
$434.7 - $599.3 $22,604 - $31,163
-52 Reduced 2.44%
2,079 $1.12 Million
Q1 2023

May 01, 2023

BUY
$310.63 - $364.82 $18,948 - $22,254
61 Added 2.95%
2,131 $731,000
Q3 2022

Nov 14, 2022

SELL
$296.48 - $337.87 $26,683 - $30,408
-90 Reduced 4.17%
2,070 $669,000
Q1 2022

May 16, 2022

BUY
$234.69 - $291.66 $2,112 - $2,624
9 Added 0.42%
2,160 $619,000
Q4 2021

Feb 11, 2022

BUY
$224.85 - $279.04 $483,652 - $600,215
2,151 New
2,151 $594,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $842B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Unionview, LLC Portfolio

Follow Unionview, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Unionview, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Unionview, LLC with notifications on news.